Innovation Webinar Series: Introduction to Innovation Concepts

Innovation Webinar Series: Intro to Innovation

Thursday, March 3rd at 12pm PST
Broadcasting at OSU in Gilbert 324 with snacks provided.

Graduate students work on innovative projects that generate new knowledge in the form of ideas, designs, and solutions to problems that are of great interest to industry. The intellectual property that belongs to students and faculty is valuable and original. How should a researcher act in order to take their high-value ideas to commercial interests? How do scientists and engineers successfully take intellectual property discovered in the pursuit of fundamental research and bring it to the marketplace?

Join the CSMC for a kickoff to our Innovation webinar series with an “Introduction to Innovation.” Come listen and ask questions with our panel of experts in concepts of intellectual property assessment, entrepreneurial support, and assessing the patentability/marketability of university generated technologies. Our panelists are Ken Vaughn from Oregon Best, Dr. Eric Evitt from ERE Consulting, Inc., and Dr. Paul Hippenmeyer from the Office of Technology Management at Washington University.

Register for the webinar:

Panelist: Ken Vaughn

Ken Vaughn leads the Oregon BEST Commercialization Program that includes grants, investments and entrepreneurial support for cleantech innovators in Oregon.  This program targetsuniversity researchers and private entrepreneurs that have new cleantech products that are transitioning from the development phase to the commercial phase.  Ken manages Oregon BEST’s commercialization funding activities that lead to the investment of about $1.5M per year with a maximum investment of $250k per project.  He also manages a portfolio of 40+ existing investments.  He collaborates with innovators, investors, mentors, support organizations and senior management talent to help assemble the elements necessary for launching a successful business in the cleantech sector.  Before joining Oregon BEST, he held senior management positions in engineering, product management and marketing in a wide range of industries.  He has experience in managing innovation, starting companies, advising early-stage companies, and investing in early-stage ventures.

Panelist: Dr. Paul Hippenmeyer

Paul Hippenmeyer is a Business Development Manager in the Office of Technology Management at Washington University since November 2015. He is responsible for the evaluation ofUniversity generated technologies for patentability/marketability and for licensing those promising technologies to corporate entities. Prior to Washington University, Paul was a Senior Licensing and Business Development Associate at the University of Missouri-Columbia for 6 years. Paul has 20+ years in the pharma/biotech drug discovery space with senior scientific leadership roles in several therapeutic areas and in technology development. He was Director of Research at Keel Pharmaceuticals in Cambridge, MA; a start-up biotechnology company. In addition, he held several positions at Monsanto, Searle and Pharmacia where he rose to Science Fellow and Senior Research Advisor. He has 20+ peer reviewed publications and review articles as well as several patents. He was formerly an Assistant Vice President for the Association of University Technology Managers (AUTM), responsible for the annual Licensing Survey.

Panelist: Dr. Eric Evitt

Dr. Evitt has more than 30 years of catalysis, chemical and chemical process R&D and R&D management experience; 20 with Catalytica or its corporate progeny, followed by 14 asanindependent consultant. His expertise includes intellectual property assessment, process development and inter-company joint R&D. At Catalytica, Dr. Evitt held various positions, including Senior Management. In 1996, he and a business development colleague co-founded Single-Site Catalysts, to supply the polyolefins industry with custom organometallics used as catalyst components for preparation of “metallocene” polymers. Today that business continues to operate within a >$3billion/yr specialty chemicals company. Dr. Evitt completed his B.S. in Chemistry at the University of Rochester, his Ph.D. in Chemistry at the California Institute of Technology, and was a Post-doctoral Fellow at Stanford University, before joining Catalytica. More recently, in 2011, he obtained his registration as a U.S. Patent Agent.